Literature DB >> 9016843

Ganglioside spinal cord changes in chronic relapsing experimental allergic encephalomyelitis induced in the Lewis rats.

E Zaprianova1, D Deleva, B Hauttecoeur, M Bakalska, A Filchev.   

Abstract

Chronic relapsing experimental allergic encephalomyelitis (CREAE) was induced in Lewis rats by inoculation with guinea-pig myelin and complete Freund's adjuvant followed by treatment with low-dose cyclosporin A. Rats were sacrified at different phases of the disease (just before the onset of clinical signs, during the first clinical episode of CREAE and during the first recovery). Gangliosides were extracted from the spinal cord, analysed after purification by two-dimensional chromatography and quantified densitometrically. An increase of GM 1, the main rat myelin ganglioside, and a decrease of GT1b, suggested to play a role in mediating the interactions between oligodendroglia and axons, were observed during the development of the CREAE. These findings indicating significant ganglioside changes in CREAE give further support to the concept concerning the involvement of gangliosides in autoimmune demyelination.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9016843     DOI: 10.1023/a:1027315607412

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  16 in total

Review 1.  Autoimmune demyelination in the central nervous system.

Authors:  T Tabira
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

2.  The pathophysiology of myelin basic protein-induced acute experimental allergic encephalomyelitis in the Lewis rat.

Authors:  M P Pender
Journal:  J Neurol Sci       Date:  1988-09       Impact factor: 3.181

3.  Immunohistological analysis of macrophages in the central nervous system of Lewis rats with acute experimental allergic encephalomyelitis.

Authors:  C H Polman; C D Dijkstra; T Sminia; J C Koetsier
Journal:  J Neuroimmunol       Date:  1986-05       Impact factor: 3.478

4.  Multiple sclerosis-like disease induced in rabbits by immunization with brain gangliosides.

Authors:  O Cohen; B A Sela; M Schwartz; N Eshhar; I R Cohen
Journal:  Isr J Med Sci       Date:  1981-08

5.  Biochemical changes in central nervous system membranes in chronic-relapsing experimental allergic encephalomyelitis.

Authors:  S Salvati; A Confaloni; A DiBiase; L Attorri; G Serlupi Crescenzi
Journal:  Mol Chem Neuropathol       Date:  1990-06

6.  The neuropathology of chronic relapsing experimental allergic encephalomyelitis induced in the Lewis rat by inoculation with whole spinal cord and treatment with cyclosporin A.

Authors:  M P Pender; G P Stanley; G Yoong; K B Nguyen
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

7.  Myelin gangliosides in vertebrates.

Authors:  F B Cochran; R K Yu; R W Ledeen
Journal:  J Neurochem       Date:  1982-09       Impact factor: 5.372

8.  A solvent partition method for microscale ganglioside purification.

Authors:  S Ladisch; B Gillard
Journal:  Anal Biochem       Date:  1985-04       Impact factor: 3.365

9.  Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin.

Authors:  B Schwerer; H Lassmann; K Kitz; H Bernheimer
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

10.  Low-dose cyclosporin A induces relapsing remitting experimental allergic encephalomyelitis in the Lewis rat.

Authors:  C H Polman; I Matthaei; C J de Groot; J C Koetsier; T Sminia; C D Dijkstra
Journal:  J Neuroimmunol       Date:  1988-02       Impact factor: 3.478

View more
  2 in total

1.  Serum ganglioside patterns in multiple sclerosis.

Authors:  E Zaprianova; D Deleva; P Ilinov; E Sultanov; A Filchev; L Christova; B Sultanov
Journal:  Neurochem Res       Date:  2001-02       Impact factor: 3.996

2.  Ganglioside changes in brain in chronic relapsing experimental allergic encephalomyelitis induced in the Lewis rat.

Authors:  E Zaprianova; D Deleva; A Filchev
Journal:  Neurochem Res       Date:  1998-11       Impact factor: 3.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.